Medical Training AIAlzheimer's Disease Management
You'll be able to work up cognitive decline, select and monitor disease-modifying and symptomatic therapy, and manage behavioral symptoms with a clear diagnostic and treatment framework.
What this track covers
This track covers the clinical evaluation and staging of Alzheimer's disease, including cognitive testing, biomarkers, and neuroimaging alongside differential diagnosis. It also addresses disease-modifying and symptomatic therapy, monitoring for treatment-related complications, and management of behavioral symptoms and caregiver needs.
What you will practice
- Distinguishing Alzheimer's from other causes of cognitive decline using history and exam findings
- Interpreting cognitive screening results and knowing when to pursue biomarker or imaging workup
- Weighing patient selection criteria and monitoring requirements for anti-amyloid therapy, including ARIA surveillance
- Choosing between and combining cholinesterase inhibitors and memantine, and adjusting for polypharmacy
- Approaching agitation, psychosis, and sleep disturbance with non-pharmacologic strategies before medication changes
Simulator scenario
A virtual patient presenting with progressive memory loss and a family member concerned about safety at home, requiring the clinician to work through diagnostic workup and an initial management plan.
Board question topics
- Cognitive assessment and staging criteria
- Biomarker and neuroimaging interpretation
- Anti-amyloid therapy patient selection and ARIA monitoring
- Pharmacologic and non-pharmacologic management of behavioral symptoms
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free